```mermaid
flowchart TD
P2RY12["P2RY12<br/>Microglial Receptor"]
TREM2["TREM2<br/>Microglial Activation"]
Neuroinflammation["Neuroinflammation<br/>Chronic Inflammation"]
ALS["ALS<br/>Motor Neuron Disease"]
Neurodegeneration["Neurodegeneration<br/>Neural Cell Death"]
MTOR["mTOR<br/>Growth Signaling"]
ULK1["ULK1<br/>Autophagy Initiator"]
ATG5["ATG5<br/>Autophagosome Formation"]
LC3["LC3<br/>Autophagosome Marker"]
SQSTM1["SQSTM1/p62<br/>Cargo Adapter"]
Autophagy["Autophagy<br/>Cellular Cleanup"]
APOA1["APOA1<br/>Cholesterol Transport"]
ABCG1["ABCG1<br/>Cholesterol Efflux"]
Foam_Cell["Foam Cell<br/>Formation"]
Lipid_Accumulation["Lipid Accumulation<br/>in Microglia"]
P2RY12 -->|"expressed in"| TREM2
P2RY12 -->|"biomarker for"| Neuroinflammation
P2RY12 -->|"associated with"| ALS
P2RY12 -->|"associated with"| Neurodegeneration
P2RY12 -->|"inhibits"| MTOR
P2RY12 -->|"inhibits"| ULK1
P2RY12 -->|"inhibits"| ATG5
P2RY12 -->|"activates"| LC3
P2RY12 -->|"activates"| SQSTM1
ULK1 -->|"initiates"| Autophagy
ATG5 -->|"promotes"| Autophagy
P2RY12 -->|"regulates"| Autophagy
P2RY12 -->|"inhibits"| APOA1
P2RY12 -->|"inhibits"| ABCG1
P2RY12 -->|"promotes"| Foam_Cell
P2RY12 -->|"promotes"| Lipid_Accumulation
style P2RY12 fill:#006494
style Autophagy fill:#1b5e20
style APOA1 fill:#1b5e20
style ABCG1 fill:#1b5e20
style Neuroinflammation fill:#ef5350
style
P2Ry12 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
<div class="infobox infobox-gene"> [@haynes2006]
<table> [@davalos2005]
<tr><th colspan="2" style="background:#f0f0f0; text-align:center;">P2RY12</th></tr> [@burnstock2009]
<tr><td><b>Full Name</b></td><td>Purinergic Receptor P2Y12</td></tr> [@mildner2017]
<tr><td><b>Chromosomal Location</b></td><td>3q25.1-q25.2</td></tr> [@international2015]
<tr><td><b>NCBI Gene ID</b></td><td>29128</td></tr> [@nalls2014]
<tr><td><b>OMIM</b></td><td>[609821](https://www.omim.org/entry/609821)</td></tr> [@gu2021]
<tr><td><b>UniProt ID</b></td><td>[Q9H0Y9](https://www.uniprot.org/uniprotkb/Q9H0Y9/entry)</td></tr>
<tr><td><b>Ensembl ID</b></td><td>[ENSG00000170017](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170017)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ad" style="color:#ef9a9a">AD</a>, <a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">ALZHEIMER</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/ami" style="color:#ef9a9a">AMI</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-f99ce4ca" style="color:#ce93d8" title="Score: 0.50">Purinergic P2Y12 Inverse Agonist Therapy...</a><br><a href="/hypothesis/h-5daecb6e" style="color:#ce93d8" title="Score: 0.46">Microglial Purinergic Reprogramming...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">277 edges</a></td>
</tr>
</table>
</div>
The P2RY12 gene encodes the purinergic receptor P2Y12 (P2Y12R), a G protein-coupled receptor (GPCR) that plays a critical role in microglial activation, neuroinflammation, and purinergic signaling in the central nervous system. P2RY12 is highly expressed on [microglia](/cell-types/microglia-neuroinflammation) and mediates their chemotactic response to neuronal injury, making it a key player in neuroimmune responses[@illes2021].
P2RY12 is a Gi/o protein-coupled receptor for ADP that plays a critical role in microglial surveillance and neuroimmune responses in the brain. It is highly expressed on microglia and mediates their chemotactic response to neuronal injury. P2RY12 is essential for microglial process extension toward sites of neurodegeneration[@haynes2006].
In the healthy brain, P2RY12-expressing microglia maintain continuous surveillance of their environment. These cells extend and retract processes to scan for signs of injury or infection. When [neurons](/entities/neurons) release ATP or ADP in response to damage, P2RY12 detects these danger signals and directs microglial processes toward the injured site[@davalos2005].
Upon ADP binding, P2RY12 activates Gi/o proteins, leading to:
P2RY12 is part of the purinergic signaling network that includes:
P2RY12 shows highest expression in:
P2RY12 is predominantly expressed in:
In Alzheimer's disease, P2RY12 plays a dual role:
P2RY12 in Parkinson's disease:
P2RY12 contributes to MS pathophysiology:
In ALS:
| Agent | Mechanism | Development Status | Indication |
|-------|-----------|-------------------|------------|
| ADP analogs | Direct P2RY12 activation | Preclinical | Neuroprotection |
| Ticagrelor derivatives | Selective agonism | Discovery | Anti-inflammatory |
| Agent | Mechanism | Development Status | Indication |
|-------|-----------|-------------------|------------|
| Ticagrelor | Reversible antagonist | Clinical trials | MS, stroke |
| Prasugrel | Irreversible antagonist | Approved (cardiac) | Investigational |
| Brilinta (BTK combinations) | P2Y12/BTK | Preclinical | Neuroinflammation |
The study of P2Ry12 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
The following diagram shows the key molecular relationships involving P2RY12 Gene discovered through SciDEX knowledge graph analysis: